Researchers from Harvard T H Chan School of Public Health in the US conducted a systematic literature search and meta- analysis to quantify the relationship between alcohol intake and non melanoma skin cancer (NMSC).
Several types of skin cancer fall within the broader category of NMSC, with the most common types being basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC).
A total of 13 case-control and cohort studies were included in the systematic review, with 95,241 NMSC cases.
Researchers found that for every 10 gramme increase in alcohol intake per day there was a positive correlation for BCC and cSCC.
"Because alcohol drinking is a prevalent and modifiable behaviour, it could serve as an important public health target to reduce the global health burden of NMSC," researchers said.
The study was published in the British Journal of Dermatology.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
